|
|
ASH 2005 Webcast
IMF reports from the 2005 annual meeting of the American Society of Hematology in Atlanta Georgia. In addition to special interviews with the researchers presenting at ASH, a special, CME-accredited program, New Agents andNew Opportunities for Multiple Myeloma - Today and Tomorrow, brought together leading experts to discuss changing clinical practice in the context of new agents and new discoveries.
|
|
|
|
|
Julian Adams, talks about the devlopment of Velcade and his latest work in developing groundbreaking approaches to the treatment of myeloma |
|
|
|
|
The IMF is pleased to provide you with a broad sampling of myeloma presentations and posters from the 2005 annual meeting of the American Society of Hematology in San Diego, California. We hope you will find this material informative and useful. |
|
|
|
|
IMF reports from the 2005 annual meeting of the American Society of Hematology in Atlanta Georgia. In addition to special interviews with the researchers presenting at ASH, a special, CME-accredited program, New Agents and New Opportunities for Multiple Myeloma - Today and Tomorrow, brought together leading experts to discuss changing clinical practice in the context of new agents and new discoveries. |
|
|
back
print
back to top